1. Whiting, DR, Guariguata, L, Weil, C, Shaw, J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311-321.
Google Scholar | Crossref | Medline | ISI2. de Boer, IH, Rue, TC, Hall, YN, Heagerty, PJ, Weiss, NS, Himmelfarb, J. Temporal trends in the prevalence of diabetic kidney disease in the United States. JAMA. 2011;305:2532-2539.
Google Scholar | Crossref | Medline | ISI3. Parving, HH, Lewis, JB, Ravid, M, Remuzzi, G, Hunsicker, LG; DEMAND Investigators . Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69:2057-2063.
Google Scholar | Crossref | Medline | ISI4. US Renal Data System . USRDS 2012 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2012.
Google Scholar5. Selby, NB . An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Supplement: Diabetes and Chronic Kidney Disease: Optimizing Outcomes for Cardiorenal Protection. 2020;22(1):3-12.
Google Scholar | Crossref6. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group . KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1-150.
Google Scholar7. Rossing, P, Hougaard, P, Parving, HH. Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study. Kidney Int. 2005;68(4):1446-1450.
Google Scholar | Crossref | Medline | ISI8. Parving, HH, Lewis, JB, Ravid, M, Remuzzi, G, Hunsicker, LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int. 2006;69(11):2057-2063.
Google Scholar | Crossref | Medline | ISI9. Kiconco, R, Rugera, SP, Kiwanuka, GN. Microalbuminuria and traditional serum biomarkers of nephropathy among diabetic patients at Mbarara regional referral Hospital in south western Uganda. J Diabetes Res. 2019;2019:3534260.
Google Scholar | Crossref | Medline10. Nathan, DM, Genuth, S, Lachin, J, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
Google Scholar | Crossref | Medline | ISI11. Nathan, DM . The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care. 2014;37:9-16.
Google Scholar | Crossref | Medline | ISI12. Huxley, RR, Peters, SA, Mishra, GD, Woodward, M. Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: a systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2015;3:198-206.
Google Scholar | Crossref | Medline | ISI13. Cho, YH, Craig, ME, Donaghue, KC. Puberty as an accelerator for diabetes complications. Pediatr Diabetes. 2014;15:18-26.
Google Scholar | Crossref | Medline14. Bergenstal, RM . Glycemic variability and diabetes complications: does it matter? Simply put, there are better glycemic markers! Diabetes Care. 2015;38:1615-1621.
Google Scholar | Crossref | Medline | ISI15. Hilliard, ME, Mann, KA, Peugh, JL, Hood, KK. How poorer quality of life in adolescence predicts subsequent type 1 diabetes management and control. Patient Educ Couns. 2013;91:120-125.
Google Scholar | Crossref | Medline | ISI16. Fadrowski, JJ, Furth, SL. GFR estimation in children: questions and answers (and questions). Clin J Am Soc Nephrol. 2011;6(8):1810-1812.
Google Scholar | Crossref | Medline17. Tziomalos, K, Athyros, VG. Diabetic nephropathy: new risk factors and improvements in diagnosis. Rev Diabet Stud. 2015;12(1-2):110-118.
Google Scholar | Crossref | Medline18. Uwaezuoke, SN . The role of novel biomarkers in predicting diabetic nephropathy: a review. Int J Nephrol Renovasc Dis. 2017;10:221-231.
Google Scholar | Crossref | Medline19. Forbes, JM, Cooper, ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137-188.
Google Scholar | Crossref | Medline | ISI20. Adiga, US, Malawadi, BN. Association of diabetic nephropathy and liver disorders. J Clin Diagn Res. 2016;10(10):BC05-BC07.
Google Scholar21. Zhao, Y, Zhu, R, Wang, D, Liu, X. Genetics of diabetic neuropathy: systematic review, meta-analysis and trial sequential analysis. Ann Clin Transl Neurol. 2019;6(10):1996-2013.
Google Scholar | Crossref | Medline